60.22 USD
▼-3.16-4.99%
盘后 59.21 -1.68%
2026-09-15
市值
$582.64M
市盈率
—
EPS
-2.01
股息率
—
52 周区间
44.25 – 123.75
成交量
58.91K
Beta
-0.11
目标价
169.49
52W 低 44.2552W 高 123.75
价格走势
公司简介
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neurop...